Trial Profile
A Real-Life, Multicenter, Retrospective Study Investigating the Effect of Thrombopoietin Receptor Agonists (Romiplostim and Eltrombopag) in Adult Patients with Primary Immune Thrombocytopenia (Itp)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2018
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary) ; Romiplostim (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Adverse reactions; Therapeutic Use
- 21 Jul 2018 New trial record
- 17 Jun 2018 Results presented at the 23rd Congress of the European Haematology Association.